Rare and orphan diseases impact under 200,000 people in the U.S., while ultra-complex challenges affect fewer than 50,000—posing unique operational challenges that demand special incentives and support for research and access.

Advanced technology therapies are innovative solutions that use advanced technology to modify, repair, or replace abnormal genes or cells, focusing on rare disorders—and face major challenges like manufacturing scalability, supply chain bottlenecks, strict regulatory demands, high costs, and the need for process standardization. In 2025, nearly 95,000 Americans are newly treated with advanced technology therapies each year, with models projecting the eligible population to exceed 100,000 annually by the early 2030s.

Discover the right mix of solutions tailored to your specific access challenges

Bring our experts to your team for customized training sessions

Collaborate on research and thought leadership initiatives

We recognized that clients with complex operational needs face overwhelming barriers when trying to access the solutions they need. Approval processes, coverage denials, and complex approval processes were keeping clients from their goals.

We recognized that clients with complex operational needs face overwhelming barriers when trying to access the solutions they need. Approval processes, coverage denials, and complex approval processes were keeping clients from their goals.

Today, we’re the trusted partner for organizations seeking to improve client success. Our platform identifies barriers in real-time and enables immediate interventions, ensuring clients get the solutions they need when they need them.